Preparation and application of ischemic myocardial targeted mitochondria-directed peptide compound
A technique for targeting peptides and mitochondria, applied in the field of biomedicine, can solve the problems of decreased activity of mitochondrial electron transport chain complexes, decreased mitochondrial DNA transcription regulation function, increased mitochondrial matrix volume, etc. Application value, effect of increasing effectiveness
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0037] The invention provides a method for preparing a mitochondrial targeting peptide complex, comprising the following steps:
[0038] Step 1: Combining TPPh3, namely 5-carboxypentyl-triphenylphosphonium bromide, with cardiomyocyte targeting peptide CSTSMLKAC to chemically synthesize TPP + + CSTSMLKAC targeting peptide;
[0039] Step 2: Use the tissue mitochondrial isolation kit to isolate and purify mitochondria;
[0040] Step 3: Dissolve the dissolved TPP ++CSTSMLKAC guide peptide resuspended purified mitochondrial pellet, incubate on shaker at 4°C for 20 minutes in the dark, then incubate at 4°C for 20 minutes to allow mitochondria and TPP + +CSTSMLKAC guide peptide is fully combined to form mitochondria-TPP-CSTSMLKAC guide peptide complex, after centrifugation, resuspend with phosphate buffer to a concentration of 7.5-10×10 4 pc / ml mitochondrial suspension, keep it on ice for later use.
[0041] The invention provides a TPP + Use of targeting peptides combined with ...
Embodiment
[0053] as attached figure 1 : It is a schematic diagram of the technical route of the mitochondria-TPP+CSTSMLKAC complex of the present invention for treating ischemic myocardial injury through vein transplantation.
[0054] 1. Combining TPPh3 (TPPh3=5-carboxypentyl-triphenylphosphine bromide) with cardiac targeting peptide CSTSMLKAC to chemically synthesize TPP+CSTSMLKAC targeting peptide, and dissolving it in PBS at 10 mg / ml to prepare TPP+CSTSMLKAC targeting peptide suspension .
[0055] 2. Obtain the myocardium of mitochondria-specific green fluorescent mice, use a tissue mitochondrial isolation kit to separate and purify mitochondria (Beyond Biotechnology Co., Ltd., C3606), and resuspend the purified mitochondrial pellet with dissolved TPP+CSTSMLKAC targeting peptide to avoid Incubate on a shaker at 4°C for 20 minutes, then incubate at 4°C for 20 minutes to fully combine mitochondria with TPP+CSTSMLKAC targeting peptide to form: mitochondria-TPP-CSTSMLKAC targeting pepti...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com